119 related articles for article (PubMed ID: 14507272)
1. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms.
Bolan CD; Wesley RA; Yau YY; Cecco SA; Starling J; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1403-13. PubMed ID: 14507272
[TBL] [Abstract][Full Text] [Related]
2. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects.
Bolan CD; Cecco SA; Yau YY; Wesley RA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1414-22. PubMed ID: 14507273
[TBL] [Abstract][Full Text] [Related]
3. Hypocalcemic symptoms during plateletpheresis using the COBE Spectra: a comparison of oral combination of 600mg calcium+300mg magnesium+100IU vitamin D3 vs. a 1000mg calcium in symptomatic donors.
Palfi M; Martinsson L; Sundström K
Transfus Apher Sci; 2007 Jun; 36(3):291-5. PubMed ID: 17613274
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
[TBL] [Abstract][Full Text] [Related]
5. Calcium and magnesium levels during automated plateletpheresis in normal donors.
Das SS; Chaudhary R; Khetan D; Shukla JS; Agarwal P; Mishra RB
Transfus Med; 2005 Jun; 15(3):233-6. PubMed ID: 15943708
[TBL] [Abstract][Full Text] [Related]
6. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
7. A liquid calcium+vitamin D
Weinstein R; Haynes S; Zhao Y; Hickson E; Linden J; St Pierre P; Ducharme P; Sulmasy P; Graves M; Bailey JA; Welch L; Simard A; Vauthrin M; Greene M
J Clin Apher; 2018 Feb; 33(1):60-64. PubMed ID: 28653765
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study.
Pandey PK; Tiwari A; Agarwal N; Dara RC
Asian J Transfus Sci; 2020; 14(1):19-22. PubMed ID: 33162700
[TBL] [Abstract][Full Text] [Related]
9. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis.
Mercan D; Bastin G; Lambermont M; Dupont E
Transfusion; 1997 Apr; 37(4):418-22. PubMed ID: 9111280
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors.
Haddad S; Leitman SF; Wesley RA; Cecco S; Yau YY; Starling J; Rehak NN; Bolan CD
Transfusion; 2005 Jun; 45(6):934-44. PubMed ID: 15934992
[TBL] [Abstract][Full Text] [Related]
11. Bone Turnover Markers Changes Induced by Plateletpheresis May Be Minimized with Oral Supplementation of Calcium, Minerals, and Vitamin D before the Procedures: A Non-Randomized, Controlled Study.
Barrientos-Galeana E; Tolentino-Dolores MC; Morales-Hernández RM; Sámano R; Chico-Barba G; Fernández-Sánchez E; Zamora-Sánchez LJ; Alonso-López AD; López-Martínez H; Alba-Rosales T; Sánchez-Guerrero SA
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615081
[TBL] [Abstract][Full Text] [Related]
12. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation.
Bolan CD; Cecco SA; Wesley RA; Horne M; Yau YY; Remaley AT; Childs RW; Barrett AJ; Rehak NN; Leitman SF
Transfusion; 2002 Jul; 42(7):935-46. PubMed ID: 12375668
[TBL] [Abstract][Full Text] [Related]
13. Serial monitoring of ionised calcium levels in plateletpheresis donors: A study from tertiary care oncology centre in India.
Navkudkar A; Desai P; Rajadhyaksha S
Transfus Apher Sci; 2022 Jun; 61(3):103350. PubMed ID: 35012841
[TBL] [Abstract][Full Text] [Related]
14. Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis.
Garg K; Kaur P; Bedi RK; Gupta S
Transfus Clin Biol; 2021 Aug; 28(3):239-245. PubMed ID: 33965622
[TBL] [Abstract][Full Text] [Related]
15. Dietary citrate and plasma ionized calcium: Implications for platelet donors.
Haynes S; Hickson E; Linden J; St Pierre P; Ducharme P; Sulmasy P; Welch L; Zhao Y; Greene M; Vauthrin M; Weinstein R
J Clin Apher; 2018 Jun; 33(3):222-225. PubMed ID: 28802068
[TBL] [Abstract][Full Text] [Related]
16. Calcium supplementation attenuates citrate-related changes in bone metabolism: a placebo-controlled crossover study in healthy volunteers.
Chen Y; Hou J; Chen G; Lin H; Lin H; Chu X; Zeng J; Chen C; Lin J; Dettke M
Bone; 2011 Sep; 49(3):506-12. PubMed ID: 21635981
[TBL] [Abstract][Full Text] [Related]
17. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
Lokhande T; Thomas S; Kumar G; Bajpai M
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
[TBL] [Abstract][Full Text] [Related]
18. QTc prolongation in apheresis platelet donors.
Laspina SJ; Browne MA; McSweeney EN; Lawlor J; Whelan DM; Kinsella AL; Murphy WG
Transfusion; 2002 Jul; 42(7):899-903. PubMed ID: 12375663
[TBL] [Abstract][Full Text] [Related]
19. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.
Despotis GJ; Goodnough LT; Dynis M; Baorto D; Spitznagel E
Vox Sang; 1999; 77(1):24-32. PubMed ID: 10474087
[TBL] [Abstract][Full Text] [Related]
20. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.
Bristow SM; Gamble GD; Stewart A; Horne L; House ME; Aati O; Mihov B; Horne AM; Reid IR
Br J Nutr; 2014 Nov; 112(10):1611-20. PubMed ID: 25274192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
